Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

585 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
Cortes J, Calvo V, Ramírez-Merino N, O'Shaughnessy J, Brufsky A, Robert N, Vidal M, Muñoz E, Perez J, Dawood S, Saura C, Di Cosimo S, González-Martín A, Bellet M, Silva OE, Miles D, Llombart A, Baselga J. Cortes J, et al. Among authors: baselga j. Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535. Ann Oncol. 2019. PMID: 30624662 Free article. No abstract available.
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
Cortes J, Calvo V, Ramírez-Merino N, O'Shaughnessy J, Brufsky A, Robert N, Vidal M, Muñoz E, Perez J, Dawood S, Saura C, Di Cosimo S, González-Martín A, Bellet M, Silva OE, Miles D, Llombart A, Baselga J. Cortes J, et al. Among authors: baselga j. Ann Oncol. 2012 May;23(5):1130-1137. doi: 10.1093/annonc/mdr432. Epub 2011 Oct 4. Ann Oncol. 2012. PMID: 21976387 Free article. Review.
Pharmacodynamic endpoints in primary breast cancer.
Di Cosimo S, Baselga J. Di Cosimo S, et al. Among authors: baselga j. Ann Oncol. 2007 Jul;18 Suppl 9:ix21-3. doi: 10.1093/annonc/mdm288. Ann Oncol. 2007. PMID: 17631590 Free article. Review. No abstract available.
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors.
Serrano C, Cortés J, De Mattos-Arruda L, Bellet M, Gómez P, Saura C, Pérez J, Vidal M, Muñoz-Couselo E, Carreras MJ, Sánchez-Ollé G, Tabernero J, Baselga J, Di Cosimo S. Serrano C, et al. Among authors: baselga j. Ann Oncol. 2012 Apr;23(4):897-902. doi: 10.1093/annonc/mdr348. Epub 2011 Aug 9. Ann Oncol. 2012. PMID: 21828361 Free article.
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors.
Serrano C, Cortés J, De Mattos-Arruda L, Bellet M, Gómez P, Saura C, Pérez J, Vidal M, Muñoz-Couselo E, Carreras MJ, Sánchez-Ollé G, Tabernero J, Baselga J, Di Cosimo S. Serrano C, et al. Among authors: baselga j. Ann Oncol. 2019 Jul 1;30(7):1178. doi: 10.1093/annonc/mdy534. Ann Oncol. 2019. PMID: 30624599 Free article. No abstract available.
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.
Swain SM, Baselga J, Miles D, Im YH, Quah C, Lee LF, Cortés J. Swain SM, et al. Among authors: baselga j. Ann Oncol. 2014 Jun;25(6):1116-21. doi: 10.1093/annonc/mdu133. Epub 2014 Mar 31. Ann Oncol. 2014. PMID: 24685829 Free PMC article. Clinical Trial.
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.
Baselga J, Manikhas A, Cortés J, Llombart A, Roman L, Semiglazov VF, Byakhov M, Lokanatha D, Forenza S, Goldfarb RH, Matera J, Azarnia N, Hudis CA, Rozencweig M. Baselga J, et al. Ann Oncol. 2019 Jun 1;30(6):1017. doi: 10.1093/annonc/mdy529. Ann Oncol. 2019. PMID: 30624616 Free PMC article. No abstract available.
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.
Baselga J, Manikhas A, Cortés J, Llombart A, Roman L, Semiglazov VF, Byakhov M, Lokanatha D, Forenza S, Goldfarb RH, Matera J, Azarnia N, Hudis CA, Rozencweig M. Baselga J, et al. Ann Oncol. 2014 Mar;25(3):592-598. doi: 10.1093/annonc/mdt543. Epub 2014 Jan 8. Ann Oncol. 2014. PMID: 24401928 Free PMC article. Clinical Trial.
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).
Ciruelos EM, Cortés J, Cortés-Funes H, Mayordomo JI, Bermejo B, Ojeda B, García E, Rodríguez CA, Muñoz M, Gómez P, Manso L, Andrés R, Lluch A, Saura C, Mendiola C, Baselga J. Ciruelos EM, et al. Among authors: baselga j. Ann Oncol. 2010 Jul;21(7):1442-1447. doi: 10.1093/annonc/mdp536. Epub 2009 Nov 25. Ann Oncol. 2010. PMID: 19940004 Free article. Clinical Trial.
585 results